| Modified mRNA vaccines protect against Zika virus infection JM Richner, S Himansu, KA Dowd, SL Butler, V Salazar, JM Fox, ... Cell 168 (6), 1114-1125. e10, 2017 | 884 | 2017 |
| T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections Y Furuta, K Takahashi, K Shiraki, K Sakamoto, DF Smee, DL Barnard, ... Antiviral research 82 (3), 95-102, 2009 | 548 | 2009 |
| PSI-7851, a Pronucleotide of β-d-2′-Deoxy-2′-Fluoro-2′-C-Methyluridine Monophosphate, Is a Potent and Pan-Genotype Inhibitor of Hepatitis C Virus … AM Lam, E Murakami, C Espiritu, HMM Steuer, C Niu, M Keilman, H Bao, ... Antimicrobial agents and chemotherapy 54 (8), 3187-3196, 2010 | 205 | 2010 |
| BCX4430–a broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease R Taylor, P Kotian, T Warren, R Panchal, S Bavari, J Julander, S Dobo, ... Journal of infection and public health 9 (3), 220-226, 2016 | 185 | 2016 |
| Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model JG Julander, V Siddharthan, J Evans, R Taylor, K Tolbert, C Apuli, ... Antiviral research 137, 14-22, 2017 | 168 | 2017 |
| Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106 JG Julander, K Shafer, DF Smee, JD Morrey, Y Furuta Antimicrobial agents and chemotherapy 53 (1), 202-209, 2009 | 158 | 2009 |
| Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models JD Morrey, CW Day, JG Julander, LM Blatt, DF Smee, RW Sidwell Antiviral Chemistry and Chemotherapy 15 (2), 67-75, 2004 | 156 | 2004 |
| Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential M Zasloff, AP Adams, B Beckerman, A Campbell, Z Han, E Luijten, I Meza, ... Proceedings of the National Academy of Sciences 108 (38), 15978-15983, 2011 | 130 | 2011 |
| Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses JT Nguyen, DF Smee, DL Barnard, JG Julander, M Gross, MD de Jong, ... PLoS One 7 (1), e31006, 2012 | 116 | 2012 |
| Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity TP Monath, CK Lee, JG Julander, A Brown, DW Beasley, DM Watts, ... Vaccine 28 (22), 3827-3840, 2010 | 112 | 2010 |
| BCX4430, a novel nucleoside analog, effectively treats yellow fever in a Hamster model JG Julander, S Bantia, BR Taubenheim, DM Minning, P Kotian, JD Morrey, ... Antimicrobial Agents and Chemotherapy 58 (11), 6607-6614, 2014 | 102 | 2014 |
| Error-prone replication of West Nile virus caused by ribavirin CW Day, DF Smee, JG Julander, VF Yamshchikov, RW Sidwell, ... Antiviral research 67 (1), 38-45, 2005 | 100 | 2005 |
| Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model JG Julander, DW Trent, TP Monath Vaccine 29 (35), 6008-6016, 2011 | 80 | 2011 |
| Fetal demise and failed antibody therapy during Zika virus infection of pregnant macaques DM Magnani, TF Rogers, NJ Maness, ND Grubaugh, N Beutler, VK Bailey, ... Nature communications 9 (1), 1624, 2018 | 76 | 2018 |
| Effect of T-705 treatment on western equine encephalitis in a mouse model JG Julander, DF Smee, JD Morrey, Y Furuta Antiviral research 82 (3), 169-171, 2009 | 73 | 2009 |
| Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus JG Julander, RJ Colonno, RW Sidwell, JD Morrey Antiviral research 59 (3), 155-161, 2003 | 69 | 2003 |
| Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus JG Julander, RW Sidwell, JD Morrey Antiviral research 55 (1), 27-40, 2002 | 68 | 2002 |
| Complete genome sequences of three historically important, spatiotemporally distinct, and genetically divergent strains of Zika virus: MR-766, P6-740, and PRVABC-59 SI Yun, BH Song, JC Frank, JG Julander, IA Polejaeva, CJ Davies, ... Genome announcements 4 (4), 10.1128/genomea. 00800-16, 2016 | 63 | 2016 |
| A heterocyclic molecule with significant activity against dengue virus V Nair, G Chi, Q Shu, J Julander, DF Smee Bioorganic & medicinal chemistry letters 19 (5), 1425-1427, 2009 | 62 | 2009 |
| C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection JG Julander, R Skirpstunas, V Siddharthan, K Shafer, JD Hoopes, ... Antiviral research 78 (3), 230-241, 2008 | 62 | 2008 |
